Anonymous User | Login

Almac - Drug Development Solutions

Drug Development Solutions

Company Product List

White Papers

Press Releases

Case Studies

Almac provides the most comprehensive range of integrated drug development solutions to enable accelerated development from research through to commercialisation.

With over 30 years experience serving over 600 clients including all the world leading pharmaceutical and biotech companies, Almac is a financially stable and privately owned organisation employing over 2,200 individuals within the US and EU.

Each customer is guaranteed a dedicated hands-on project management service to meet individual needs ensuring clients will experience continued success in all their ventures.

Our comprehensive range of services includes:

Research

Almac provide genomics based solutions, informing drug discovery and enabling personalised medicine. Our services include:

Biomarker discovery and validation
Bioinformatic solutions
Genomic services
Medicinal chemistry support

Chemical and pharmaceutical development

Almac accelerate the development of customers' drug candidates through the effective integration of science and manufacturing to provide drug substance and product:

API supply (including potent, peptide, cytotoxic and chiral compounds)
Solid state services
Isotope labelling
Product development
Analytical services
Accelerated first in man

Clinical development

Almac is a recognised leader in the preparation of clinical trial supplies. Our technology solutions provide unrivalled access to data critical to the efficient management of clinical trials:

Comparator blinding
Packaging and labelling
QP release
Global distribution (including cold chain)
IVR / Web
ePRO
EDC
Adaptive trial design

Commercial

Almac provides solid dosage from commercial manufacture and packaging for EU and US markets. Commercial support services facilitate EU market access for non-EU product: